NORTHAMPTON, MA / ACCESSWIRE / / IlluminaThe comprehensive method provides improved detection and greater insight on the ...

TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...

A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...

Cincinnati Bengals wide receiver Ja'Marr Chase danced a touchdown celebration against the Dallas Cowboys in honor of Texas boy's Brixton Wood cancer battle.

Adverse events associated with ponatinib in CML and ALL were shown to have decreased significantly since its approval, ...

Novel triple-drug therapies have shown promise for various leukemia types, achieving high remission and response rates. Key ...

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

Moleculin Biotech shares are trading higher on Wednesday after the company announced the online publication of preclinical ...

Edward Viner, MD, retired acting chief of medicine at Pennsylvania Hospital in Philadelphia and chief of medicine emeritus at Cooper University Hospital in Camden, N.J., died of acute myeloid leukemia ...

Edward Viner, MD, a retired chief of medicine, pioneer of inpatient care and oncologist, died Dec. 1 of acute myeloid leukemia at age 89, The Philadelphia Inquirer reported.

(RTTNews) - Moleculin Biotech, Inc. (MBRX), Wednesday announced the preliminary activity of Annamycin in heavily pretreated, relapsed/refractory acute myeloid leukemia or AML patients who had ...

LYNPARZA® (olaparib) Demonstrated Clinically Meaningful Prolonged Survival Benefit in Early Breast Cancer in OlympiA Phase 3 Trial ...